The health ministry of Russia approved a flu drug to be used in the fight against the deadly novel coronavirus after the preliminary testing showed promising results. The drug "Avifavir" -- a generic version of the Japanese flu drug "Avigan" -- has been granted a temporary registration certificate as Russia's first COVID-19 drug, according to the Russian Direct Investment Fund (RDIF)’s official statement. RDIF has been taking several effective steps in fighting the pandemic, which included a project to diagnose and treat COVID-19-related pneumonia using CT scans and artificial intelligence technology. Avifavir has been used to treat severe forms of...